Prestige Wealth Management Group’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-21
Closed -$380 – 1070
2023
Q2
$380 Hold
21
– – ﹤0.01% 1013
2023
Q1
$352 Hold
21
– – ﹤0.01% 1021
2022
Q4
$431 Buy
+21
New +$370 ﹤0.01% 1084

Other funds holding OFIX

Prestige Wealth Management Group's OFIX Position: Q3 2023 in Review

Prestige Wealth Management Group sold out of Orthofix Medical (OFIX) in Q3 2023, closing a stake of 21 shares — an estimated $380 sold.

Prestige Wealth Management Group first reported a position in OFIX in Q4 2022 and held it in 3 quarters. The position peaked at $431 in Q4 2022. 159 funds tracked by Wall St. Rank hold OFIX as of Q3 2023.

  • Prestige Wealth Management Group reported no remaining Orthofix Medical position as of Q3 2023 after selling out during the quarter.
  • Prestige Wealth Management Group sold 21 Orthofix Medical shares in Q3 2023, an estimated $380.
  • Prestige Wealth Management Group first reported a position in Orthofix Medical in Q4 2022 and held it in 3 quarters.
  • Prestige Wealth Management Group's Orthofix Medical position peaked at $431 in Q4 2022.
  • 159 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2023.

Based on Prestige Wealth Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.